在接受化疗或放射治疗的宫癌女性中,身体组成表型与治疗毒性之间的关联
Mariah Azevedo Aredes1, Nathália Silva de Paula2, Gabriela Villaça Chaves3
1Nutrition and Cancer Research Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
下骨肌指数 (SMI) 与宫癌患者的化学放射治疗毒性增加有关. 不良的体质构成显著增加了治疗修改的风险,影响了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 身体组成分析 身体成分分析
背景情况:
- 宫癌的治疗通常涉及化疗和放射治疗.
- 身体成分可能会影响治疗毒性和治疗结果.
- 了解这些关联可以优化患者的护理.
研究的目的:
- 在宫癌患者中研究身体组成表型和化疗放射性毒性之间的关系.
- 识别与不良事件和治疗修改相关的特定体质成分标记.
主要方法:
- 对330名接受化疗或放射治疗的宫癌患者进行前性队列研究.
- 计算机断层扫描 (CT) 扫描评估了骨肌肉指数 (SMI),骨肌肉放射密度 (SMD) 和脂肪组织指数.
- 每周对毒性和毒性诱导的治疗修改 (TIMT) 进行监测.
主要成果:
- 几乎一半的患者至少有一个不良的身体成分参数.
- 观察到更高的等级≥3毒性 (55%) 和TIMT (30%) 的比率.
- 较低的SMI是不良事件的关键预测因素,特别是与较低的SMD或正常脂肪度相结合时.
- 所有的身体成分表型都与TIMT有关,结合不良特征增加了风险.
结论:
- 较低的SMI是使用化疗放射治疗的宫癌患者增加不良事件的独立风险因素.
- 肌肉质量低,脂肪组织过多的女性面临治疗延迟或中断的风险高出四倍.
- 不良的身体组成参数的累积效应显著提高了TIMT的风险.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Cancer Prevention
Some...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Dose-Response Relationship: Overview
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
